4.8 Article

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation

Journal

IMMUNITY
Volume 43, Issue 1, Pages 161-174

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2015.05.019

Keywords

-

Categories

Funding

  1. NIH [AI026918, AI030663, AI078869, HL107202, K08DK101604]
  2. UCSF Diabetes Family Fund
  3. UCSF REAC Pilot Grant
  4. Sandler Asthma Basic Research Center at UCSF
  5. Howard Hughes Medical Institute

Ask authors/readers for more resources

Group 2 innate lymphoid cells (ILC2s) and regulatory T (Treg) cells are systemically induced by helminth infection but also sustain metabolic homeostasis in adipose tissue and contribute to tissue repair during injury. Here we show that interleukin-33 (IL-33) mediates activation of ILC2s and Treg cells in resting adipose tissue, but also after helminth infection or treatment with IL-2. Unexpectedly, ILC2-intrinsic IL-33 activation was required for Treg cell accumulation in vivo and was independent of ILC2 type 2 cytokines but partially dependent on direct co-stimulatory interactions via ICOSL-ICOS. IFN-gamma inhibited ILC2 activation and Treg cell accumulation by IL-33 in infected tissue, as well as adipose tissue, where repression increased with aging and high-fat diet-induced obesity. IL-33 and ILC2s are central mediators of type 2 immune responses that promote tissue and metabolic homeostasis, and IFN-gamma suppresses this pathway, likely to promote inflammatory responses and divert metabolic resources necessary to protect the host.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available